NYMOX PHARMACEUTICAL CORP (NYMXF) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$4.5M

Total Assets (FY2024)

$654.0K

Total Equity (FY2024)

-$6.8M

Cash Flows from Operating Activities (FY2024)

-$2.6M

Source: NYMOX PHARMACEUTICAL CORP 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.